The investigation of SIRT7 reveals its potential role as a predictive biomarker for aggressive PCa [170], characterized by a lack of reliable prognostic indicators, with immunohistochemical analysis of 57 patients showing significantly elevated SIRT7 expression in tumor tissues compared to adjacent healthy tissues and a positive correlation with cancer grade [98]. This evidence concerns the gene SIRT7 and cancer.